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Cross-clamping of the aorta at the thoracic level produces a dangerous hypertension which may lead to rupture of the dissection into pericardium as in Case 4. Arfonad was given to lower the systolic pressure to 90 mm Hg before applying clamps. Occlusion of the aorta above the diaphragm may result in renal and spinal cord damage if it is maintained for over one hour, and I find it difficult to complete the fenestration in a shorter time. The induction of hypothermia offers protection; it was used in 2 cases but it involves an extra hazard for the patient.
Control of hypertension in the post-operative period is most important and a level of about 150/90 should be maintained with the use of drugs such as Ansolysen. It is significant that this step was omitted for Case 3 who died of aortic rupture in the sixth week when the pressure was 170/110.
DISCUSSION
Mr Peter Martin (Chelmsford) said that though he had been interested in dissecting aneurysms for some time his experience had been limited as he had seen but 6 patients with the condition, and operated on only 3. He had also had the opportunity of examining some others at autopsy.
There are two points he wished to make about the diagnosis. (1) It seemed that ECG changes suggesting a posterior myocardial infarct were common when a dissecting aneurysm and no infarction was present. This might obscure the diagnosis and had in fact done so in one of his patients. (2) Changing distal pulses were pathognomonic of dissecting aneurysm. For example, the right femoral pulse might be absent, but at examination a short time later the right might be present and the left absent.
The surgical treatment of dissecting aneurysm in the main mimicked nature by creating a port of re-entry from the extraluminal back into the intraluminal channel of the aorta. Of the 3 patients he had operated on one was living and well eighteen months afterwards, one returned to work but died a year to the day after operation and the third died ten days after operation. Both those who died, did so from intrapericardial rupture of the outer layer of the extraluminal channel, this channel being patent throughout its course. The third and living patient was one with a chronic dissecting aneurysm. In the post-mortem specimens he had seen, the extraluminal channel had always been patent. In all the cases he had seen death had occurred from rupture of the outer layer of the false channel.
Rupture of the extraluminal channel was just as likely to occur whether there was a port of re-entry or not. It was said that the natural recovery rate of dissecting aneurysm was 20 to 25 %. He wondered if patients subjected to surgery might not well have survived had they been treated conservatively. Possibly hypotensive drug treatment might be best for those who survive the initial catastroDhe. There are, in common use at the present time, many different ways of attempting to control disseminated breast cancer by hormonal methods. But not one of these does more than give merely temporary respite to at best some 50 % of patients and each may be followed by unpleasant, or even dangerous, side-effects and Qomplications. It is therefore not surprising that the history of the evolution of endocrine therapy of breast cancer is one of waves of enthusiasm, followed by disillusionment and rejection, and that even to-day it is difficult to decide what advice to give the individual patient.
It is also apparent that, until new and better forms of treatment become available, the most urgent requirement is to find means of selection so that existing methods, especially those of a major character, aie offered only to those patien-ts who are likely to benefit and that the others are spared the distress of unsuccessful treatment.
This paper reports the results of certain investigations into thi-s problem. The basic plan of the investigation was to study-the response of individual patients to the successive administration of testosterone, oophorectomy, stilbcestrol, corticosteroids and finally either adrenalectomy or hypophysectomy, in order that response to the major forms of therapy could be related to response to the simpler procedures. In all 112 women have been under observation and the majority followed to the inevitable termination. Of course no patient received each of the treatments mentioned but all had at least three and many four or five different types of treatment. In each case treatment was changed only when it was ineffective and when symptoms demanded relief. At the time of change all hormone administration was discontinued for ten to fourteen days before starting the new regime.
The results have been classified as effective or ineffective according to the following criteria:
Treatment was considered to be effective if it induced, for a period of more than two months, both worth-while subjective relief and unequivocal objective evidence of regression of the disease, as shown for example by regression of cutaneous lesions or radiological evidence of improvement in bone or lung metastases. Treat-ment was considered ineffective if it exercised a beneficial effect for less than two months, or if it failed to do any good, or if response was mixedthat is if regression of one lesion was accompanied by progression of any other manifestation of the disease. In other words treatment was regarded as effective only when the beneficial results were unequivocal, of reasonable duration, and indeed readily appreciated by all concerned.
The main points that have emerged are:
First, in 500% of all women breast cancer is completely resistant to all forms of endocrine therapy. A similar claim was made by Huggins & Dao in 1954, but other workers have cast doubt on this rigid classification because it is known, for example, that failure to respond to cestrogens, or androgens, may be followed by improvement after adrenalectomy or hypophysectomy (Strong et al. 1956 ). The second point is the fundamental importance of ovarian function on the effects of hormone therapy, a factor which is readily apparent in the observations made during the course of this study.
Testosterone proprionate was administered by intramuscular injection, in doses of 100 mg, three times a week, to 32 pre-menopausal women but was effective in only 7 (21 %) of these, and in 2 appeared to induce an exacerbation, although in every case testosterone was quickly effective in suppressing menstruation. Testosterone was also given to 33 women who were two or more years past the natural menopause and proved effective in 12 (36 Y.). Testosterone was thus effective nearly twice as often after, as it was before, the menopause. The main disadvantages of treatment by androgens are that the most effective preparations must be given by injection and that some 70% of subjects develop hirsuties and change in voice.
Nausea and vomiting may also occur. Many patients will bear these unpleasant side-effects with fortitude, but the others are profoundly distressed and for this reason and also because, as will be shown later, oophorectomy appears to be better than testosterone for the younger women and stilboestrol for the older women, I have now abandoned the use of testosterone.
Oophorectomy was performed on 70 patients and proved effective in 27 (45%) of the 60 of those who were pre-menopausal. Only once did death follow within a month of operation and this in a woman who was virtually moribund beforehand from pulmonary metastases. The only unpleasant side-effects were menopausal symptoms, which occurred in 7 % of the subjects. In 30 out of the 60 *of these young women, menstruation had ceased following the administration of testosterone and in another 7 menstruation had ceased following external irradiation of the ovaries. But in both groups the operation was as effective as it was in the other previously untreated pre-menopausal women, suggesting that ovarian function persists despite the fact that testosterone, or external irradiation, readily suppresses menstruation. Oophorectomy was performed on ten women who were four or more years past the natural menopause and in each of these was ineffective.
Stilbwestrol was administered in doses of 5 mg three times a day to 42 women who were two or more years past the natural menopause and was effective in 15 (35%) of these. The only harmful effects were nausea and vomiting which occurred in 3 of the 42 patients and fluid retention which appeared to precipitate congestive heart failure in one patient. The nausea and vomiting responded to the administration of chlorpromazine or anti-histamine drugs. At the start of the investigation stilboestrol was given to 9 pre-menopausal women but in each case was ineffective and indeed appeared to produce an exacerbation in one woman. Its use for pre-menopausal patients was therefore abandoned, especially as other reports of its ineffectiveness in young women appeared at this time (Foss 1956 , Lewison et al. 1956 ).
Prednisolone was administered to a group of 45 women. The regime employed was to give 20 mg twice a day for ten days and then reduce each dose by 5 mg every other day until a maintenance level of 5 mg twice a day was reached. Ten out of the 45 women were pre-menopausal and not one of these was benefited in any way, but of the 35 women in whom ovarian function had ceased following oophorectomy, or the natural menopause, 15, or nearly 43%, gained worth-while benefit which in many cases lasted as long as two or three years. In addition to producing objective signs of improvement, in 43 % of post-menopausal patients, prednisolone had a mild euphoric and tonic effect on almost all patients. The drug is easy to take and in the above doses seldom produced 'moon face' or other side-effects. The greatest danger was that after prolonged administration signs of acute adrenal insufficiency followed sudden withdrawal or severe stress such as an operation or acute infection. Only 2 patients complained of dyspeptic symptoms and both responded to the administratiui7 -f alkalies and to a change to enteric coated tablets.
Combined bilateral adrenalectomy and oophorectomy, according to published accounts of large series, affords worth-while relief to some 47 % of patients (Hadfield 1959) . The operation is technically satisfactory and carries a low mortality, but it is nevertheless a painful procedure for the patient and many surgeons are reluctant to undertake such a major operation when faced with a less than fifty-fifty chance of substantial benefit. It therefore seemed important to discover to what extent the beneficial results were due to oophorectomy, how much to physical removal of the adrenal glands and how much to the corticosteroids which must be given to maintain life following operation.
In an attempt to answer these questions 12 pre-menopausal women were submitted first to oophorectomy, later to corticosteroid therapy and finally to surgical removal of the adrenal glands.
Thie results showed that under these circumstances surgical adrenalectomy was valueless as it added nothing to the benefits already obtained, irrespective of whether or not oophorectomy and steroid therapy had proved effective. Furthermore, the results of combined oophorectomy and steroid therapy in our hands, as well as those of others (Brinkley & Pillers 1960) , are about the same as those which have been reported from combined bilateral adrenalectomy and oophorectomy. For these reasons it would appear that adrenalectomy can now be abandoned as a form of therapy for breast cancer.
Surgical hypophysectomy has been reported as yielding 48 % of beneficial results in large series of patients (Hadfield 1959) . But this operation can be technically difficult and unsatisfactory in so far as it often fails to ensure complete ablation of the gland, and is furthermore attended by a not inconsiderable mortality and morbidity so that here again there is an understandable reluctance in recommending the procedure and a real need for a satisfactory method of predicting the outcome. Eighteen of the women in the present series were submitted to surgical hypophysectomy. Five of these were pre-menopausal and 13 post-menopausal. The operation was effective in 8 patients and ineffective in 10. But the point of interest is that hypophysectomy proved effective only in those in whom the disease had been found endocrine-dependent as judged by response to prior oophorectomy and steroid therapy in the younger Women, or stilboestrol and steroid therapy in the older women. Hypophysectomy was ineffective in those women in whom the tumour was uninfluenced by the other forms of endocrine therapy.
These results could be summarized as follows:
(1) In 500% of all women breast cancer is completely resistant to all forms of endocrine therapy.
(2) Ovarian function has a profound influence on the effects on breast cancer of testosterone, stilboestrol, oophorectomy and corticosteroids.
(3) Prednisolone is a valuable therapeutic agent for breast cancer, provided that ovarian function has ceased.
(4) The primary treatment of choice for disseminated breast carcinoma is oophorectomy followed by prednisolone, for the pre-menopausal woman, and a combination of stilbeestrol and prednisolone, for the post-menopausal woman.
(5) Adrenalectomy adds nothing to the benefits obtained from the above forms of primary treatment but hypophysectomy may give further worth-while relief to women in whom the tumour has proven responsive to the primary endocrine therapy. The regime described is both simple and humane and furthermore provides a useful means of selecting patients who are likely to benefit from hypophysectomy.
This work was done in the University Department of Surgery, at the Royal Infirmary in Sheffield. I am indebted to my former colleagues for referring many of the patients and to Mr Anthony Jefferson for performing the hypophysectomies.
